First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas
Authors:
- Jan Oliver DittmarJDJan Oliver Dittmar
- Clemens KratochwilCKClemens Kratochwil
- Anne DittmarADAnne Dittmar
- Thomas WelzelTWThomas Welzel
- Daniel HabermehlDHDaniel Habermehl
- Stefan RiekenSRStefan Rieken
- Frederik L. GieselFGFrederik L. Giesel
- Uwe HaberkornUHUwe Haberkorn
- Jürgen DebusJDJürgen Debus
- Stephanie E. CombsSCStephanie E. Combs
Open Access
- 6 November 2017
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 12 (1) , 169
Abstract
For irradiation treatment planning of meningiomas the use of PET-scans is well established. The most frequently used tracers are either based on amino acids or the somatostatin receptor ligand DOTATOC. Since up to now no inter-institutionally accepted standard PET-tracer has been defined, the aim of this study was to evaluate the influence of these different types of PET-tracers on the GTV-definition. Twenty-one patients suffering from intracranial meningiomas underwent CT, MRI, FET- and DOTATOC-PET. First, tumour extension was delineated after image-fusion of CT and MRI (GTVCT/MRI). Then distinct GTVs based either on FET- or DOTATOC-PET were contoured and compared with each other as well with GTVCT/MRI. Every tumour showed typical enhancement of DOTATOC, but two meningiomas remained FET-negative. The mean relative overlap volume of GTVFET and GTVDOTATOC was only 41.9% and there was a significantly stronger correlation between GTVCT/MRI and GTVDOTATOC than between GTVCT/MRI and GTVFET . Further investigations are necessary to clarify the minor conformity of DOTATOC- and FET-PET in meningiomas. Because of the receptor targeting, DOTATOC is known to be more specific for meningiomas and will remain the standard in our institution with the known limitation in areas nearby the pituitary gland.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (KFO 214)
This publication has 36 references indexed in Scilit:
- Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT Treatment Planning for Meningioma: First ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Carbon ion radiation therapy for high-risk meningiomasRadiotherapy and Oncology, 2010
- Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumourJournal of Clinical Neuroscience, 2010
- [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planningRadiation Oncology, 2009
- Radiotherapy and radiosurgery for benign skull base meningiomasRadiation Oncology, 2009
- Effect of 11C-Methionine-Positron Emission Tomography on Gross Tumor Volume Delineation in Stereotactic Radiotherapy of Skull Base MeningiomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- PET/CT of Skull Base Meningiomas Using 2-18F-Fluoro-L-Tyrosine: Initial ReportJournal of Nuclear Medicine, 2007
- O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology, 2006
- Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: Long-term experience and prognostic factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- DOTATOC: A powerful new tool for receptor-mediated radionuclide therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997